Zobrazeno 1 - 10
of 32
pro vyhledávání: '"A. L. Grigorieva"'
Autor:
V. G. Potapenko, D. S. Abramov, V. V. Baykov, T. L. Grigorieva, M. S. Selinkina, L. O. Nikolskaya, J.-F. Emile
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 46-55 (2024)
Rosai–Dorfman disease is the most frequent variant of non-Langerhans cell histiocytosis. Local forms can be resected or irradiated. If the process involves multiple organs, systemic chemotherapy can cure some patients. This article includes literat
Externí odkaz:
https://doaj.org/article/0bc85939f3a44ecd89631a05b86cb997
Autor:
E. N. Gladkova, O. M. Lesnyak, A. G. Zakroeva, I. Z. Gaydukova, A. L. Grigorieva, Yu. A. Safonova
Publikováno v:
Osteoporosis and Bone Diseases. 25:4-13
Background: The growing frequency of fractures associated with osteoporosis, the significant costs of their treatment, disability and increased mortality make it an important and urgent task to optimize the diagnosis and treatment of osteoporosis in
Autor:
Galina S. Zamay, Tatiana I. Ivanchenko, Tatiana N. Zamay, Valentina L. Grigorieva, Yury E. Glazyrin, Olga S. Kolovskaya, Irina V. Garanzha, Andrey A. Barinov, Alexey V. Krat, Gleb G. Mironov, Ana Gargaun, Dmitry V. Veprintsev, Sergey S. Bekuzarov, Andrey K. Kirichenko, Ruslan A. Zukov, Marina M. Petrova, Andrey A. Modestov, Maxim V. Berezovski, Anna S. Zamay
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 6, Iss , Pp 150-162 (2017)
Nucleic acid aptamers are becoming popular as molecular probes for identification and imaging pathology and, at the same time, as a convenient platform for targeted therapy. Recent studies have shown that aptamers may be effectively used for tumor ch
Externí odkaz:
https://doaj.org/article/6c14b9fd44a045fcbb7b57e303f76361
Publikováno v:
Scholarly Notes of Komsomolsk-na-Amure State Technical University. :33-40
Autor:
T. L. Karonova, Denis A Lebedev, A. Yu. Babenko, M. A. Kokina, Elena Grineva, Alena Andreeva, N. V. Timkina, A. L. Grigorieva
Publikováno v:
Osteoporosis and Bone Diseases. 24:4-9
Background: Sodium glucose co-transporter type 2 inhibitors (iSGLT2) are antihyperglycemic drugs approved for the treatment of type 2 diabetes mellitus (T2DM). Clinical trials with these drugs have shown evidence of an increased risk of fractures and
Autor:
Maxim A. Chepurnykh, Natalia S. Lomakina, Igor N. Аlkhimenko, Ksenia D. Кhryapenko, Yan Yu. Grigoriev, Anna L. Grigorieva
Publikováno v:
Scholarly Notes of Komsomolsk-na-Amure State Technical University. :19-28
Publikováno v:
Scholarly Notes of Komsomolsk-na-Amure State Technical University. :68-72
Autor:
L. Grigorieva, O. Makarova
Publikováno v:
Ecological Sciences. 34:22-25
Publikováno v:
Trudy MAI.
Autor:
Elena G. Kirikutsa, Alla V. Khromenko, Galina N. Dudukalova, Vladimir V. Dudukalov, Olga L. Grigorieva
Publikováno v:
Сooperation and Sustainable Development ISBN: 9783030769994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cac390355b6624565068e84dd29add5
https://doi.org/10.1007/978-3-030-77000-6_38
https://doi.org/10.1007/978-3-030-77000-6_38